Compile Data Set for Download or QSAR
maximum 50k data
Found 85 Enz. Inhib. hit(s) with all data for entry = 50038182
TargetMatrix metalloproteinase-9(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50372815(CHEMBL404893)
Affinity DataIC50:  3.80nMAssay Description:Inhibition of catalytic domain MMP9More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMatrix metalloproteinase-9(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50230534((S)-3-(N-(4-(4-chlorophenoxy)phenyl)methan-15-ylsu...)
Affinity DataIC50:  4.70nMAssay Description:Inhibition of catalytic domain MMP9More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMatrix metalloproteinase-9(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50372817(CHEMBL401821)
Affinity DataIC50:  5.5nMAssay Description:Inhibition of catalytic domain MMP9More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMatrix metalloproteinase-9(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50372819(CHEMBL404882)
Affinity DataIC50:  6.60nMAssay Description:Inhibition of catalytic domain MMP9More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMatrix metalloproteinase-9(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50230517((S)-N,2-dihydroxy-3-(N-(4-(p-tolyloxy)phenyl)metha...)
Affinity DataIC50:  7.80nMAssay Description:Inhibition of catalytic domain MMP9More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMatrix metalloproteinase-9(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50372818(CHEMBL429927)
Affinity DataIC50:  12nMAssay Description:Inhibition of catalytic domain MMP9More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMatrix metalloproteinase-9(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50372816(CHEMBL403089)
Affinity DataIC50:  13nMAssay Description:Inhibition of catalytic domain MMP9More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMatrix metalloproteinase-9(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50230529((S)-N,2-dihydroxy-3-(N-(4-(4-(trifluoromethyl)phen...)
Affinity DataIC50:  14nMAssay Description:Inhibition of catalytic domain MMP9More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target72 kDa type IV collagenase(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50372817(CHEMBL401821)
Affinity DataIC50:  20nMAssay Description:Inhibition of full length MMP2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMatrix metalloproteinase-9(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50372812(CHEMBL411519)
Affinity DataIC50:  28nMAssay Description:Inhibition of catalytic domain MMP9More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMatrix metalloproteinase-9(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50372820(CHEMBL403169)
Affinity DataIC50:  31nMAssay Description:Inhibition of catalytic domain MMP9More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target72 kDa type IV collagenase(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50372797(CHEMBL272763)
Affinity DataIC50:  32nMAssay Description:Inhibition of full length MMP2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target72 kDa type IV collagenase(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50230534((S)-3-(N-(4-(4-chlorophenoxy)phenyl)methan-15-ylsu...)
Affinity DataIC50:  35nMAssay Description:Inhibition of full length MMP2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target72 kDa type IV collagenase(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50372815(CHEMBL404893)
Affinity DataIC50:  36nMAssay Description:Inhibition of full length MMP2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMatrix metalloproteinase-9(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50372804(CHEMBL270010)
Affinity DataIC50:  39nMAssay Description:Inhibition of catalytic domain MMP9More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMatrix metalloproteinase-9(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50372799(CHEMBL403110)
Affinity DataIC50:  44nMAssay Description:Inhibition of catalytic domain MMP9More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target72 kDa type IV collagenase(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50372799(CHEMBL403110)
Affinity DataIC50:  47nMAssay Description:Inhibition of full length MMP2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMatrix metalloproteinase-9(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50372798(CHEMBL272984)
Affinity DataIC50:  47nMAssay Description:Inhibition of catalytic domain MMP9More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMatrix metalloproteinase-9(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50372806(CHEMBL258300)
Affinity DataIC50:  54nMAssay Description:Inhibition of catalytic domain MMP9More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMatrix metalloproteinase-9(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50372802(CHEMBL408906)
Affinity DataIC50:  54nMAssay Description:Inhibition of catalytic domain MMP9More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target72 kDa type IV collagenase(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50372798(CHEMBL272984)
Affinity DataIC50:  56nMAssay Description:Inhibition of full length MMP2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target72 kDa type IV collagenase(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50372819(CHEMBL404882)
Affinity DataIC50:  61nMAssay Description:Inhibition of full length MMP2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target72 kDa type IV collagenase(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50230517((S)-N,2-dihydroxy-3-(N-(4-(p-tolyloxy)phenyl)metha...)
Affinity DataIC50:  61nMAssay Description:Inhibition of full length MMP2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target72 kDa type IV collagenase(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50372818(CHEMBL429927)
Affinity DataIC50:  67nMAssay Description:Inhibition of full length MMP2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMatrix metalloproteinase-9(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50372807(CHEMBL270229)
Affinity DataIC50:  69nMAssay Description:Inhibition of catalytic domain MMP9More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target72 kDa type IV collagenase(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50372820(CHEMBL403169)
Affinity DataIC50:  73nMAssay Description:Inhibition of full length MMP2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMatrix metalloproteinase-9(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50372797(CHEMBL272763)
Affinity DataIC50:  91nMAssay Description:Inhibition of catalytic domain MMP9More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMatrix metalloproteinase-9(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50372808(CHEMBL270230)
Affinity DataIC50:  93nMAssay Description:Inhibition of catalytic domain MMP9More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target72 kDa type IV collagenase(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50372816(CHEMBL403089)
Affinity DataIC50:  102nMAssay Description:Inhibition of full length MMP2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMatrix metalloproteinase-9(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50372801(CHEMBL429571)
Affinity DataIC50:  104nMAssay Description:Inhibition of catalytic domain MMP9More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMatrix metalloproteinase-9(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50372811(CHEMBL270023)
Affinity DataIC50:  124nMAssay Description:Inhibition of catalytic domain MMP9More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target72 kDa type IV collagenase(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50230529((S)-N,2-dihydroxy-3-(N-(4-(4-(trifluoromethyl)phen...)
Affinity DataIC50:  139nMAssay Description:Inhibition of full length MMP2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target72 kDa type IV collagenase(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50372812(CHEMBL411519)
Affinity DataIC50:  142nMAssay Description:Inhibition of full length MMP2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target72 kDa type IV collagenase(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50372823(CHEMBL404270)
Affinity DataIC50:  147nMAssay Description:Inhibition of full length MMP2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMatrix metalloproteinase-9(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50372813(CHEMBL257725)
Affinity DataIC50:  242nMAssay Description:Inhibition of catalytic domain MMP9More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMatrix metalloproteinase-9(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50372805(CHEMBL258301)
Affinity DataIC50:  243nMAssay Description:Inhibition of catalytic domain MMP9More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target72 kDa type IV collagenase(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50372804(CHEMBL270010)
Affinity DataIC50:  247nMAssay Description:Inhibition of full length MMP2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target72 kDa type IV collagenase(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50372801(CHEMBL429571)
Affinity DataIC50:  283nMAssay Description:Inhibition of full length MMP2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMatrix metalloproteinase-9(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50372810(CHEMBL270868)
Affinity DataIC50:  286nMAssay Description:Inhibition of catalytic domain MMP9More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target72 kDa type IV collagenase(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50372813(CHEMBL257725)
Affinity DataIC50:  286nMAssay Description:Inhibition of full length MMP2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target72 kDa type IV collagenase(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50372802(CHEMBL408906)
Affinity DataIC50:  297nMAssay Description:Inhibition of full length MMP2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMatrix metalloproteinase-9(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50372809(CHEMBL402639)
Affinity DataIC50:  344nMAssay Description:Inhibition of catalytic domain MMP9More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target72 kDa type IV collagenase(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50372806(CHEMBL258300)
Affinity DataIC50:  344nMAssay Description:Inhibition of full length MMP2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMatrix metalloproteinase-9(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50372823(CHEMBL404270)
Affinity DataIC50:  383nMAssay Description:Inhibition of catalytic domain MMP9More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target72 kDa type IV collagenase(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50372807(CHEMBL270229)
Affinity DataIC50:  401nMAssay Description:Inhibition of full length MMP2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMatrix metalloproteinase-9(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50372803(CHEMBL269797)
Affinity DataIC50:  472nMAssay Description:Inhibition of catalytic domain MMP9More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target72 kDa type IV collagenase(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50372811(CHEMBL270023)
Affinity DataIC50:  509nMAssay Description:Inhibition of full length MMP2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target72 kDa type IV collagenase(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50372808(CHEMBL270230)
Affinity DataIC50:  582nMAssay Description:Inhibition of full length MMP2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target72 kDa type IV collagenase(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50372822(CHEMBL256018)
Affinity DataIC50:  893nMAssay Description:Inhibition of full length MMP2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMatrix metalloproteinase-9(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research And Development

Curated by ChEMBL
LigandPNGBDBM50372814(CHEMBL257724)
Affinity DataIC50:  933nMAssay Description:Inhibition of catalytic domain MMP9More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 85 total ) | Next | Last >>
Jump to: